Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2009
11/03/2009US7611865 Genetic engineering
11/03/2009US7611724 Produced from Chromobacterium cultures; depsipeptides; immunosuppressants; for treatment of graft-versus-host disease
11/03/2009US7611711 VEGFR-3 inhibitor materials and methods
11/03/2009CA2394216C Process for the preparation of peptides
10/2009
10/29/2009US20090270446 Diamine derivatives
10/29/2009US20090269806 Process for producing dipeptides
10/29/2009US20090269804 Methods for refolding proteins containing free cysteine residues
10/29/2009US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids
10/28/2009EP2111410A2 Peptide inhibitors of metallo- ectopeptidases, compositions comprising said compounds and their pharmaceutical and cosmetic uses
10/28/2009EP2111227A1 Macrocyclic hepatitis c protease inhibitors
10/28/2009EP1692098B1 Alpha-ketoamide derivative, and production method and use thereof
10/28/2009CN101568548A Isotopically labeled trapping agent and method for identifying reactive metabolites
10/28/2009CN101568346A Hcv ns3 protease inhibitors
10/28/2009CN101565453A Nitrone compound capable of capturing free radicals, preparation method thereof and use thereof
10/28/2009CN101565452A Immune 7P truncated peptide and application thereof
10/28/2009CN101565451A N-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester
10/28/2009CN101565450A N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 1-methyl ester
10/28/2009CN101565449A N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 1-methyl ester
10/28/2009CN100553639C Boronic acid polyvalent salts for treating thrombosis
10/27/2009US7608697 Mixture comprising enzymatic polypeptides with proline modified terminal for use in enhancing/reducing digestion/flavor/bitterness of foods; food processing
10/27/2009US7608696 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
10/27/2009US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009US7608685 Tumor antigen based on products of the tumor suppressor gene WT1
10/27/2009US7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608623 N- alpha -(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanine-4-ethoxycarbonylpiperazinium hydrogen sulfate; N- alpha -(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyguanidino-(L)-phenylalanine-4-ethoxycarbonylpiperazide; urokinase plasminogen activator inhibitor; anticarcinogenic agent
10/27/2009US7608592 HCV inhibitors
10/27/2009US7608591 Targeted delivery to legumain-expressing cells
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/27/2009US7608577 Peptidyl ketones as inhibitors of DPIV
10/27/2009US7608280 Method of producing FR901228
10/27/2009US7608243 RGD peptide sequence; labelled with fluorescein used as contrast agents in optical imaging in diagnosis of angiogenesis-related diseases; peptidic vector and the fluorescein dye are coupled; cyclic peptide forming disulife or monothioether bridge
10/27/2009US7608242 Peptide-chelate conjugates
10/27/2009CA2341434C Pyrrolobenzodiazepine compounds
10/22/2009WO2009127140A1 7p peptide and its derivant, the use thereof
10/22/2009WO2009106715A3 Peptide derived from a protein of the aquaporin family
10/22/2009WO2009065857A3 Compositions for reducing oxidative stress and uses thereof
10/22/2009WO2002087504A9 Methods for inhibiting tumor cell proliferation
10/22/2009WO2002044329A9 Receptor-mediated uptake of peptides that bind the human transferrin receptor
10/22/2009US20090264627 Increasing half-life of immunoglobulin fusion via alteration of carboxy-terminal with cytokine protein; directed protein evolution; antitumor agents
10/22/2009US20090264625 Method for recombinant microorganism expression and isolation of collagen-like polypeptides
10/22/2009US20090264618 Compounds With a Branched Linker
10/22/2009US20090264617 Method of producing fr901228
10/22/2009US20090264616 Cyclodipeptide Synthetases and Their Use for Synthesis of Cyclo(Leu-Leu) Cyclodipeptide
10/22/2009US20090264487 Hemiasterlin analogs
10/22/2009US20090264419 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
10/22/2009US20090264346 Macrocyclic peptides active against the hepatitis c virus
10/22/2009US20090264343 Method of producing fr901228
10/22/2009US20090263472 Endothelin receptor antagonist derivatives
10/21/2009EP2110380A1 Alpha-N-methylation of amino acids
10/21/2009EP2024387B1 Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application
10/21/2009EP1283197B1 Process for producing cinnamylaldehyde derivatives, use thereof and the like
10/21/2009CN101563359A Michael systems as transglutaminase inhibitors
10/21/2009CN101560244A New method for synthesizing argatroban by combining solid phase method and liquid phase method
10/20/2009US7605126 Acylaminoheteroaryl hepatitis C virus protease inhibitors
10/20/2009US7604970 Variants of the PapM polypeptide of bacteria of the Streptomyces genus
10/20/2009US7604811 Inducing an immune response in mammals comprising administering an antigenic synthetic peptide containing Colonization FactorAntigen/I pilus protein T-cell epitopes encapsulated within a biodegradable matrix of glycolic acid-lactic acid copolymer; amino acid sequences; intestinal bioavailability
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/15/2009US20090259021 Liquid Phase Peptide Synthesis of KL-4 Pulmonary Surfactant
10/15/2009US20090258834 Plasma protein-binding ligands
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/15/2009US20090258426 Preferred segments of neural thread protein and method of using the same
10/15/2009US20090257978 Antiviral coumpounds
10/14/2009EP2108655A1 Immune-modulating peptide
10/14/2009EP2024388B1 Peptide substance stimulating regeneration of central nervous system neurons, pharmaceutical composition on its base, and the method of its application
10/14/2009CN101557818A ATAP peptides, nucleic acids encoding the same and associated methods of use
10/14/2009CN101555271A Epitope minimum motif peptide of human zona pellucida protein
10/14/2009CN100548386C Releasable polymeric conjugates based on biodegradable linkers
10/14/2009CN100548291C MCH antagonists for the treatment of obesity
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601709 Macrocyclic hepatitis C serine protease inhibitors
10/13/2009US7601708 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals
10/13/2009US7601706 Bile-acid conjugates providing for sustained systemic concentration of drugs
10/13/2009US7601693 Synthetic anti-neuropilin 1 (NRP1) cyclic peptide containing RRXR motif
10/13/2009US7601518 Secretion of neublastin
10/13/2009CA2370830C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
10/13/2009CA2334775C Benzo(b)thiepine-1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
10/13/2009CA2318512C Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
10/08/2009WO2009123487A1 Compounds for treating pain
10/08/2009US20090253950 Radioactive member and method of making
10/08/2009US20090253896 Selective substrates for matrix metalloproteinases
10/08/2009US20090253895 Printable Materials
10/08/2009US20090253640 Inhibitors of polyisoprenylated methylated protein methyl esterase
10/08/2009US20090253635 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
10/08/2009CA2720375A1 Compounds for treating pain
10/07/2009EP2107374A1 Polypeptide for diagnosis of vaccination
10/07/2009EP2107067A1 Boron catalysed peptide synthesis
10/07/2009EP2032596B1 Neuroprotective compounds and uses thereof
10/07/2009EP1434791B1 Specific binding agents of human angiopoietin-2
10/07/2009EP1235595B8 Integrin-mediated drug targeting
10/07/2009EP1007077B1 Glutathione for the treatment of influenza infection
10/07/2009CN101553463A New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof
10/07/2009CN101550180A A liquid-phase synthesis method of tuftsin
10/06/2009US7598341 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
10/06/2009US7598340 Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
10/06/2009US7598253 Reverse-turn mimetics and methods relating thereto
10/06/2009US7598235 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals
10/06/2009CA2616580C Macrocyclic inhibitors of hepatitis c virus
10/01/2009WO2009119710A1 Novel antibiotic sf2896 substance, process for production thereof, and pharmaceutical composition
10/01/2009WO2009119554A1 Promoter for bicarbonate secretion in gastrointestinal tract
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 307